scholarly article | Q13442814 |
P50 | author | J. Michael Schmidt | Q43182649 |
Brandon Foreman | Q57065601 | ||
Lawrence James Hirsch | Q88149090 | ||
Belinda Shao | Q88309949 | ||
Jan Claassen | Q89261556 | ||
Stephan A. Mayer | Q111584599 | ||
P2093 | author name string | Christine Lesch | |
Hector Lantigua | |||
Andres Fernandez | |||
P2860 | cites work | Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | Q43747004 |
Refractory status epilepticus: frequency, risk factors, and impact on outcome | Q43885520 | ||
Continuous infusion of midazolam in the treatment of refractory generalized convulsive status epilepticus | Q43998241 | ||
Refractory status epilepticus: a prospective observational study | Q44832149 | ||
Pharmacokinetics of midazolam and metabolites in a patient with refractory status epilepticus treated with extraordinary doses of midazolam | Q46788719 | ||
Refractory status epilepticus: effect of treatment aggressiveness on prognosis | Q46802749 | ||
Treatment of refractory generalized status epilepticus with continuous infusion of midazolam | Q46877372 | ||
High-dose midazolam therapy for refractory status epilepticus in children | Q48663156 | ||
Prolongation of midazolam half-life after sustained infusion for status epilepticus | Q51408618 | ||
Intravenous midazolam for the treatment of refractory status epilepticus | Q51693477 | ||
Status Epilepticus | Q59664579 | ||
Functional and cognitive outcome in prolonged refractory status epilepticus | Q82236451 | ||
Management of refractory status epilepticus in adults: still more questions than answers | Q27028089 | ||
Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit | Q27477887 | ||
APACHE II: a severity of disease classification system | Q29547729 | ||
Refractory status epilepticus | Q30436209 | ||
A randomized trial for the treatment of refractory status epilepticus. | Q34024128 | ||
Assessment of outcome after severe brain damage | Q34216702 | ||
Epilepsy emergencies: diagnosis and management | Q34250143 | ||
Propofol and midazolam in the treatment of refractory status epilepticus. | Q34301397 | ||
Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review | Q34570571 | ||
Detection of electrographic seizures with continuous EEG monitoring in critically ill patients | Q35782033 | ||
Guidelines for the evaluation and management of status epilepticus | Q38004984 | ||
Emergency neurological life support: status epilepticus | Q38041474 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | midazolam | Q423071 |
status epilepticus | Q980709 | ||
P304 | page(s) | 359-365 | |
P577 | publication date | 2013-12-20 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | High-dose midazolam infusion for refractory status epilepticus | |
P478 | volume | 82 |